Figure 1.
Structures of the novel nonpeptide sulphonamide antagonists (a) SB-706375 (2-bromo-4,5-dimethoxy-N-[3-(R)-1-methyl-pyrrolidin-3-yloxy)-4-trifluromethyl-phenyl]-benzenesulphonamide HCl) and (b) SB-657510 (2-bromo-N-[4-chloro-3-((R)-1-methyl-pyrrolidin-3-yloxy)-phenyl]-4,5-dimethoxybenzenesulphonamide HCl).